An international pharmaceutical company approached us to assist with a product launch for a private prescription drug in the General Practitioner (GP) space, a highly subsidised and competitive market.
The client’s promotional budget was limited due to the volume of aggressive competitor activity. In addition to this, their only in-house experience was within the specialty care space.
We partnered and worked collaboratively with our client to determine the key objectives, outline what success would look like, and pin down the best possible product line to combat competitor growth.
Product line two within our national sales team (24 representatives) was available and was determined to be the best fit for our client at that time. Drawing on our in-depth commercial insights, we were able to demonstrate what deployment could and would bring to their business, and we entered into a 12-month engagement.
The launch was a great success with the product gaining significant market share in the Australian GP market.
Due to this, the client approached Farmaforce to extend and upgrade their solution to ensure that their product moved to the product first line. This allowed them to establish specific targeting, engage GPs and attend key opinion leader education meetings to help drive sales further.
This partnership has been so successful and has brought so much in delivering high return on investment for our client that they have continually re-evaluated their sales forecasts upwards.
The client has since re-engaged with Farmaforce for future product launches